Company Can-Fite BioPharma Ltd. TEL AVIV STOCK EXCHANGE

CANF

IL0010944739

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Biopharmaceuticals

Inactive Instrument

Can Fite Biofarma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.

ILS in Million	2022	Weight	2023	Weight	Delta
Biopharmaceuticals 100.0 %	3	100.0 %	3	100.0 %	+0.69%

ILS in Million	2022	Weight	2023	Weight	Delta
Israel 100.0 %	3	100.0 %	3	100.0 %	+0.69%

Managers	Title	Age	Since
Motti Farbstein CEO	Chief Executive Officer	59	03-07-31
Pnina Fishman FOU	Founder	74	94-09-10
Ilan Cohn FOU	Founder	68	94-09-10
Zivit Harpaz CTO	Chief Tech/Sci/R&D Officer	-	-
Michael Silverman CTO	Chief Tech/Sci/R&D Officer	-	-
Sari Fishman PRN	Corporate Officer/Principal	52	03-12-31
William D. Kerns PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Abraham Sartani BRD	Director/Board Member	76	00-12-31
Ilan Cohn FOU	Founder	68	94-09-10
Pnina Fishman FOU	Founder	74	94-09-10
Yaacov Goldman BRD	Director/Board Member	68	17-07-31
Guy Regev BRD	Director/Board Member	55	11-06-30
Yossi Bornstein BRD	Director/Board Member	66	21-08-04

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,497,128,493	1,496,706,120 ( 99.97 %)	0	99.97 %

Name	Equities	%	Valuation
IBI Mutual Funds Management (1978) Ltd. 0.1477 %	2,210,774	0.1477 %	16 890 ₪
Alumot Sprint Mutual Funds Management Ltd. 0.0730 %	1,092,174	0.0730 %	8 344 ₪
Pnina Fishman 0.0176 %	263,433	0.0176 %	2 013 ₪
Ilan Cohn 0.008922 %	133,567	0.008922 %	1 020 ₪
Guy Regev 0.001619 %	24,240	0.001619 %	185 ₪
Ramco Mutual Funds Management (1989) Ltd. 0.001469 %	22,000	0.001469 %	168 ₪
Millennium Mutual Funds Ltd. 0.000142 %	2,120	0.000142 %	16 ₪
Motti Farbstein 0.000076 %	1,133	0.000076 %	9 ₪
Sari Fishman 0.000000 %	0	0.000000 %	- ₪
Yossi Bornstein 0.000000 %	0	0.000000 %	- ₪

Name	Equities	%	Valuation
Armistice Capital LLC 3.093 %	154,363	3.093 %	342 686 ₪
Morgan Stanley Capital Services LLC 0.9271 %	46,265	0.9271 %	102 708 ₪
Schechter Investment Advisors LLC 0.4023 %	20,077	0.4023 %	44 571 ₪
RhumbLine Advisers LP 0.3703 %	18,482	0.3703 %	41 030 ₪
FIFTH THIRD BANCORP 0.0601 %	3,000	0.0601 %	6 660 ₪
National Bank Financial, Inc. 0.0120 %	600	0.0120 %	1 332 ₪
Citigroup Global Markets, Inc. (Investment Management) 0.0111 %	553	0.0111 %	1 228 ₪
Stone House Investment Management LLC 0.009418 %	470	0.009418 %	1 043 ₪
TD Waterhouse Canada, Inc. 0.000401 %	20	0.000401 %	44 ₪

Can-Fite BioPharma Ltd.

26 Ben Gurion Street

5257346, Ramat Gan

+972 3 924 1114

http://www.canfite.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
CSL LIMITED	-4.24%	86.85B
SAMSUNG BIOLOGICS CO.,LTD.	+2.76%	40.16B
BIOGEN INC.	-16.42%	31.28B
UCB	+57.86%	25.27B
BIOMARIN PHARMACEUTICAL INC.	-15.31%	15.33B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.12%	11.96B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42.56%	11.61B
SWEDISH ORPHAN BIOVITRUM AB	+6.89%	8.83B
INNOVENT BIOLOGICS, INC.	-10.53%	7.94B

Biopharmaceuticals